Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q01DX010 (sc) |
mean tumor weight change |
saline |
0.5 mg/kg/injection |
59.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
0.5 mg/kg/injection |
99.0 |
Antitumor endpoint evaluated on day 11; 02/02 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
0.5 mg/kg/injection |
261.0 |
Antitumor endpoint evaluated on day 11; 02/02 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
0.5 mg/kg/injection |
73.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
0.5 mg/kg/injection |
168.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
0.5 mg/kg/injection |
116.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
0.5 mg/kg/injection |
127.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
1.0 mg/kg/injection |
7.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
1.0 mg/kg/injection |
53.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
1.0 mg/kg/injection |
59.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
1.0 mg/kg/injection |
99.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
1.0 mg/kg/injection |
93.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
1.0 mg/kg/injection |
209.0 |
Antitumor endpoint evaluated on day 11; 02/02 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
1.0 mg/kg/injection |
81.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
2.0 mg/kg/injection |
58.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
2.0 mg/kg/injection |
137.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
2.0 mg/kg/injection |
72.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
2.0 mg/kg/injection |
46.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
2.0 mg/kg/injection |
7.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
2.0 mg/kg/injection |
52.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
2.0 mg/kg/injection |
35.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
4.0 mg/kg/injection |
-5.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
4.0 mg/kg/injection |
17.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
4.0 mg/kg/injection |
-29.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
4.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 11; 00/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
4.0 mg/kg/injection |
-43.0 |
Antitumor endpoint evaluated on day 11; 03/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
4.0 mg/kg/injection |
-19.0 |
Antitumor endpoint evaluated on day 11; 02/03 animals surviving on day 11 |
Q01DX010 (sc) |
mean tumor weight change |
saline |
4.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 11; 01/03 animals surviving on day 11 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
8.0 |
Antitumor endpoint evaluated on day 15; 06/06 animals surviving on day 15 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
-10.0 |
Antitumor endpoint evaluated on day 15; 06/06 animals surviving on day 15 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
-61.0 |
Antitumor endpoint evaluated on day 15; 06/06 animals surviving on day 15 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 15; 00/05 animals surviving on day 15 |
Q04DX004 (sc) |
mean tumor weight change |
saline |
2.0 mg/kg/injection |
156.0 |
Antitumor endpoint evaluated on day 15; 06/06 animals surviving on day 15 |
Q04DX004 (sc) |
mean tumor weight change |
saline |
4.0 mg/kg/injection |
75.0 |
Antitumor endpoint evaluated on day 15; 06/06 animals surviving on day 15 |
Q04DX004 (sc) |
mean tumor weight change |
saline |
8.0 mg/kg/injection |
2.0 |
Antitumor endpoint evaluated on day 15; 06/06 animals surviving on day 15 |
Q04DX004 (sc) |
mean tumor weight change |
saline |
16.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 15; 00/06 animals surviving on day 15 |
Q04DX004 (sc) |
mean tumor weight change |
saline with Tween-80 |
1.0 mg/kg/injection |
75.0 |
Antitumor endpoint evaluated on day 15; 06/06 animals surviving on day 15 |
Q04DX004 (sc) |
mean tumor weight change |
saline with Tween-80 |
2.0 mg/kg/injection |
27.0 |
Antitumor endpoint evaluated on day 15; 05/05 animals surviving on day 15 |
Q04DX004 (sc) |
mean tumor weight change |
saline with Tween-80 |
4.0 mg/kg/injection |
80.0 |
Antitumor endpoint evaluated on day 15; 06/06 animals surviving on day 15 |
Q04DX004 (sc) |
mean tumor weight change |
saline with Tween-80 |
8.0 mg/kg/injection |
4.0 |
Antitumor endpoint evaluated on day 15; 05/06 animals surviving on day 15 |